Abstract
• Three main strategies for the fabrication of nanosystems are summarized. • How to produce novel Ru and Ir complexes containing nanosystems is summarized. • The recent developments in Ru and Ir complexes containing nanosystems are outlined. • The existing opportunities and challenges in nanosystems are highlighted. Ruthenium(II) and iridium(III) coordination compounds display excellent structural, photophysical, and biological properties which make them highly promising as anticancer and bioimaging agents. When nanoparticles are functionalized with Ru(II) and Ir(III) complexes, enhanced performance and synergistic effects can be produced in the resultant nanosystems. This review begins by describing the three main strategies for the fabrication of Ru(II) and Ir(III) complex containing nanosystems. This is followed by a discussion of the ways in which Ru(II) and Ir(III) complexes and nanoparticles combine and interact to produce novel materials with efficacies exceeding the sum of their parts. The main body of the review then outlines the recent developments in Ru(II) and Ir(III) complex containing nanosystems for cancer treatment and bioimaging. To conclude, some of the future challenges and opportunities in this field are highlighted.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
